Actively Recruiting
Comparing 6% and 8% Sevoflurane Inhalation for Anesthesia in Children Undergoing Minor Eye Surgery
Led by Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong · Updated on 2026-03-04
80
Participants Needed
1
Research Sites
5 weeks
Total Duration
AI-Summary
What this Trial Is About
This research aims to compare the effectiveness and safety of two concentrations of sevoflurane inhalation 6% and 8% for anesthesia induction in children aged 1 to 6 years undergoing minor ophthalmic surgery, such as chalazion excision. The study is a randomized controlled trial focusing on pediatric patients with a physical status classified as ASA I and suitable for inhalation anesthesia. Participants will be randomly assigned to receive either 6% or 8% sevoflurane inhalation through a face mask for anesthesia induction. Both groups will undergo general anesthesia maintained with sevoflurane during the minor eye surgery. The study measures include the Pediatric Anesthesia Emergence Delirium PAED scale, along with other parameters such as induction and recovery times, hemodynamic monitoring, and perioperative respiratory events. Throughout the trial, participants will be closely monitored for emergence agitation within 30 minutes after recovery, as well as for adverse events such as respiratory depression, hypoxia, coughing, nausea, and vomiting. Researchers will also record induction and recovery times immediately following anesthesia administration and discontinuation. Study participation involves careful evaluation and monitoring to assess the safety and effects of the two sevoflurane concentrations during the surgical procedure and recovery period.
CONDITIONS
Brief Title
Effect of Different Concentrations of Sevoflurane for Anesthesia Induction in Pediatric Ophthalmic Surgery
Research Team
L
Laiwen Lv, MSc.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here